Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Cytori Therapeutics Inc    CYTX

 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 6,30 M
EBIT 2016 -19,9 M
Net income 2016 -21,3 M
Debt 2016 -
Yield 2016 -
Sales 2017 11,1 M
EBIT 2017 -18,1 M
Net income 2017 -17,5 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 6,60x
Capi. / Sales2017 3,76x
Capitalization 41,6 M
More Financials
Company
Cytori Therapeutics, Inc. is a late stage cell therapy company.Its develops autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy™ acts principally... 
More about the company
Latest news on CYTORI THERAPEUTICS INC
09/24 CYTORI THERAPEUTICS : BARDA Increases Cytori Therapeutics Contract Option
09/19 CYTORI THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Financia..
09/13 CYTORI THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and E..
09/12 CYTORI THERAPEUTICS : Case Report Illustrates the Potential Value Cytori Cell Th..
09/01 CYTORI THERAPEUTICS : Receives Frost & Sullivan 2016 Technology Innovation Award
08/18 CYTORI THERAPEUTICS : Announced Inducement Grant for New Employee
08/11 CYTORI THERAPEUTICS : Reports Second Quarter 2016 Business and Financial Results
08/05 CYTORI THERAPEUTICS : Management's Discussion and Analysis of Financial Conditio..
08/05 CYTORI THERAPEUTICS : reports 2Q loss
08/04 CYTORI THERAPEUTICS, INC. : Results of Operations and Financial Condition, Chang..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
09/17DJJ&J to Buy Abbott Eye Business -- WSJ
09/16DJJ&J to Buy Abbott's Eye-Surgery Unit for $4.325 billion -- 2nd Update
09/16DJJ&J to Buy Abbott's Eye-Surgery Unit for $4.325 billion -- 3rd Update
09/16DJJ&J to Buy Abbott's Eye-Surgery Unit for $4.325 billion -- Update
09/16DJJ&J Nears Deal to buy Abbott's Eye-Surgery Equipment Unit
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
05/10 Cytori Therapeutics' (CYTX) CEO Marc Hedrick on Q1 2016 Results - Earnings Ca..
05/10 Cytori Therapeutics EPS in-line, beats on revenue
05/10 Cytori Cell Therapy an Orphan Drug in Europe for scleroderma-related hand dys..
05/09 Notable earnings after Tuesday?s close
03/24 Cytori's late-stage study of ECCS-50 in scleroderma 50% enrolled; study to co..
Advertisement
Chart CYTORI THERAPEUTICS INC
Duration : Period :
Cytori Therapeutics Inc Technical Analysis Chart | CYTX | US23283K1051 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 7,33 $
Spread / Average Target 261%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Marc H. Hedrick President, Chief Executive Officer & Director
David M. Rickey Chairman
Tiago Girão CFO, Vice President & Head-Investor Relations
John K. Fraser Chief Scientist
Mark Marino Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CYTORI THERAPEUTICS IN..-4.14%42
MEDTRONIC PLC12.68%119 620
BAXTER INTERNATIONAL I..24.06%25 671
ZIMMER BIOMET HOLDINGS..24.78%25 378
C R BARD INC20.67%16 740
SYSMEX CORP-3.07%15 359
More Results